Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28898894 | 0.83 | — | — | |
| SCHEMBL14943960 | 0.83 | — | — | |
| SCHEMBL25702934 | 0.83 | — | — | |
| SCHEMBL30097899 | 0.82 | ESR1 (0.32) | ESR1ESR2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5678569 | 0.80 | — | — | |
| SCHEMBL28306122 | 0.79 | EPHX2 (0.37) | ESR1ESR2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5678610 | 0.79 | — | — | |
| SCHEMBL2909331 | 0.78 | ADH1B (0.39) | ESR1ESR2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5680331 | 0.78 | — | — | |
| SCHEMBL28306060 | 0.77 | EPHX2 (0.35) | ESR1ESR2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1184396-B1 | (Meth)acrylate ester-based resin composition | NIPPON CATALYTIC CHEM IND (JP) | 2006-02-01 | — | — | EP | disclosed |
| US-6686413-B2 | AQUEOUS DISPERSON OF A POLYMER CONTAINING UNITS OF A CYCLOHEXYLALKYL ESTER OF (METH)ACRYLIC ACID | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-02-03 | — | — | US | disclosed |
| US-6489396-B2 | A CYCLOHEXYL CONTAINING (METH)ACRYLIC ESTER-BASED POLYMER CROSSLINKED WITH A DI-FUNCTIONAL CROSSLINKING AGENT; LOW VISCOSITY RESIN FOR LOW VOLATILE ORGANIC COMPOUND (VOC)-PAINTS | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-12-03 | — | — | US | disclosed |
| US-20020091197-A1 | (Meth)acrylate ester-based resin composition | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-07-11 | — | — | US | disclosed |
| EP-1205498-A1 | (Meth)acrylate ester-based resin composition | Nippon Shokubai Co., Ltd. (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-20020045702-A1 | (Meth)acrylate ester-based resin composition | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-1184396-A1 | (Meth)acrylate ester-based resin composition | Nippon Shokubai Co., Ltd. (JP) | 2002-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045702-A1 | (Meth)acrylate ester-based resin composition | MNAT1, MAT1A, COPE | ESR1 1004/4885ESR2 2314/4885CYP3A4 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.